Читать книгу Pathy's Principles and Practice of Geriatric Medicine - Группа авторов - Страница 461

1 1. Goyal RK, Hirano I. Mechanisms of disease: the enteric nervous system. N Engl J Med. 1996; 334:1106–1115.

2 2. Wade PR. Aging and neural control of the GI tract. I. Age‐related changes in the enteric nervous system. Am J Physiol Gastrointest Liver Physiol. 2002; 283(3):G489–495.

3 3. Phillips RJ, Martin FN, Billingsley CN, Powley TL. Alpha‐synuclein expression patterns in the colonic submucosal plexus of the aging Fischer344 rat: implications for biopsies in aging and neurodegenerative disorders? Neurogastroenterol Motil. 2013; 25(9):e621–633.

4 4. Wade PR, Cowen T. Neurodegeneration: a key factor in the ageing gut. Neurogastroenterol Motil. 2004; 16 Suppl1:19–23.

5 5. Phillips RJ, Powley TL. Innervation of the gastrointestinal tract: patterns of aging. Auton Neurosci. 2007; 136(1‐2):1–19.

6 6. Bernard CE, Gibbons SJ, Gomez‐Pinilla PJ, et al. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil. 2009; 21(7):746–e746.

7 7. Hoyle CH, Saffrey MJ. Effects of aging on cholinergic neuromuscular transmission in isolated small intestine of ad libitum fed and calorically‐restricted rats. Neurogastroenterol Motil. 2012; 24(6):586–592.

8 8. Phillips RJ, Walter GC, Powley TL. Age‐related changes in vagal afferents innervating the gastrointestinal tract. Auton Neurosci. 2009.

9 9. Rayner CK, Horowitz M. Physiology of the ageing gut. Curr Opin Clin Nutr Metab Care. 2013; 16(1):33–38.

10 10. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil. 2008; 20(4):418–429.

11 11. Zhao J, Gregersen H. Esophageal morphometric and biomechanical changes during aging in rats. Neurogastroenterol Motil. 2015; 27(11):1638–1647.

12 12. Zhao J, Gregersen H. Morphometric and biomechanical remodeling of the small intestine during aging in rats. J Biomech. 2015; 48(16):4271–4278.

13 13. Madsen JL, Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing. 2004; 33(2):154–159.

14 14. Lasch H, Castell DO, Castell JA. Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distension. Am J Physiol.1997; 272:G1–3.

15 15. Rayner CK, MacIntosh CG, Chapman IM, Morley JE, Horowitz M. Effects of age on proximal gastric motor and sensory function. Scand J Gastroenterol. 2000; 35:1041–1047.

16 16. Delvaux M, Louvel D, Lagier E, Scherrer B, Abitbol JL, Frexinos J. The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. Gastroenterology.1999; 116:38–45.

17 17. Weusten BL, Lam HG, Akkermans LM, Van Berge‐Henegouwen GP, Smout AJ. Influence of age on cerebral potentials evoked by oesophageal balloon distension in humans. Eur J Clin Invest.1994; 24:627–631.

18 18. Kahrilas PJ, Bredenoord AJ, Carlson DA, Pandolfino JE. Advances in Management of Esophageal Motility Disorders. Clin Gastroenterol Hepatol. 2018; 16(11):1692–1700.

19 19. Soergel KH, Zboralske FF, Amberg JR. Presbyesophagus: esophageal motility in nonagenarians. J Clin Invest.1964; 43:1472–1479.

20 20. Cock C, Omari T. Systematic review of pharyngeal and esophageal manometry in healthy or dysphagic older persons (>60 years). Geriatrics (Basel). 2018; 3(4).

21 21. Shaw DW, Cook IJ, Gabb M, et al. Influence of normal aging on oral‐pharyngeal and upper esophageal sphincter function during swallowing. Am J Physiol.1995; 268(3 Pt1):G389–396.

22 22. Kawamura O, Easterling C, Aslam M, Rittmann T, Hofmann C, Shaker R. Laryngo‐upper esophageal sphincter contractile reflex in humans deteriorates with age. Gastroenterology. 2004; 127(1):57–64.

23 23. Kawami N, Iwakiri K, Sano H, Tanaka Y, Sakamoto C. Effects of aging and acid reflux on esophageal motility. Digestion. 2015; 91(3):181–186.

24 24. Gregersen H, Pedersen J, Drewes AM. Deterioration of muscle function in the human esophagus with age. Dig Dis Sci. 2008; 53(12):3065–3070.

25 25. Firth M, Prather CM. Gastrointestinal motility problems in the elderly patient. Gastroenterology. 2002; 122(6):1688–1700.

26 26. Lee J, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol. 2007; 5(12):1392–1398.

27 27. Smout AJ, Breedijk M, van der Zouw C, Akkermans LM. Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24‐hour recording and automated analysis. Dig Dis Sci.1989; 34(3):372–378.

28 28. Tack J, Vantrappen G. The aging oesophagus. Gut.1997; 41:422–424.

29 29. Shaker R, Staff D. Esophageal disorders in the elderly. Gastroenterol Clin North Am. 2001; 30(2):335–361, vii–viii.

30 30. Lock G. Physiology and pathology of the oesophagus in the elderly patient. Best Pract Res Clin Gastroenterol. 2001; 15(6):919–941.

31 31. Veerappan GR, Perry JL, Duncan TJ, et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol. 2009; 7(4):420–426,426 e421‐422.

32 32. Orr WC, Chen CL. Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am J Physiol Gastrointest Liver Physiol. 2002; 283(6):G1226–1231.

33 33. Kahrilas PJ, Pandolfino JE. Treatments for achalasia in 2017: how to choose among them. Curr Opin Gastroenterol. 2017; 33(4):270–276.

34 34. Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013; 144(4):718–725; quiz e713‐714.

35 35. Craft RO, Aguilar BE, Flahive C, et al. Outcomes of minimally invasive myotomy for the treatment of achalasia in the elderly. JSLS. 2010; 14(3):342–347.

36 36. Sandler RS, Nyren O, Ekbom A, Eisen GM, Yuen J, Josefsson S. The risk of esophageal cancer in patients with achalasia. A population‐based study. Jama.1995; 274(17):1359–1362.

37 37. Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015; 27(2):160–174.

38 38. Zarowitz BJ. Pharmacologic consideration of commonly used gastrointestinal drugs in the elderly. Gastroenterol Clin North Am. 2009; 38(3):547–562.

39 39. Matsumoto Y, Senda E, Yamada H. Dabigatran‐induced esophagitis associated with vomiting. Am J Gastroenterol. 2019; 114(4):548.

40 40. Eslick GD, Fass R. Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am. 2003; 32(2):531–552.

41 41. George N, Abdallah J, Maradey‐Romero C, Gerson L, Fass R. Review article: the current treatment of non‐cardiac chest pain. Aliment Pharmacol Ther. 2016; 43(2):213–239.

42 42. Eslick GD, Talley NJ. Natural history and predictors of outcome for non‐cardiac chest pain: a prospective4‐year cohort study. Neurogastroenterol Motil. 2008; 20(9):989–997.

43 43. Achem SR, DeVault KR. Gastroesophageal reflux disease and the elderly. Gastroenterol Clin North Am. 2014; 43(1):147–160.

44 44. Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton‐pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017; 8(9):273–297.

45 45. Malfertheiner P, Kandulski A, Venerito M. Proton‐pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol. 2017; 14(12):697–710.

46 46. Pham H, Phillips L, Trahair L, Hatzinikolas S, Horowitz M, Jones KL. Longitudinal changes in the blood pressure responses to, and gastric emptying of, an oral glucose load in healthy older subjects. J Gerontol A Biol Sci Med Sci. 2019.

47 47. Gidal BE. Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res. 2006; 68 Suppl1:S65‐69.

48 48. Soenen S, Rayner CK, Horowitz M, Jones KL. Gastric emptying in the elderly. Clin Geriatr Med. 2015; 31(3):339–353.

49 49. Camilleri M, Chedid V, Ford AC, et al. Gastroparesis. Nat Rev Dis Primers. 2018; 4(1):41.

50 50. Fich A, Camilleri M, Phillips SF. Effect of age on human gastric and small bowel motility. J Clin Gastroenterol.1989; 11:416–420.

51 51. Serra‐Prat M, Mans E, Palomera E, Clave P. Gastrointestinal peptides, gastrointestinal motility, and anorexia of aging in frail elderly persons. Neurogastroenterol Motil. 2013; 25(4):291–e245.

52 52. Visvanathan R, Chapman IM. Undernutrition and anorexia in the older person. Gastroenterol Clin North Am. 2009; 38(3):393–409.

53 53. Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis. 2007; 25(2):112–117.

54 54. Husebye E, Engedal K. The patterns of motility are maintained in the human small intestine throughout the process of aging. Scand J Gastroenterol.1992; 27:397–404.

55 55. Mitsui T, Kagami H, Kinomoto H, Ito A, Kondo T, Shimaoka K. Small bowel bacterial overgrowth and rice malabsorption in healthy and physically disabled older adults. J Hum Nutr Diet. 2003; 16(2):119–122.

56 56. Schiller LR. Diarrhea and malabsorption in the elderly. Gastroenterol Clin North Am. 2009; 38(3):481–502.

57 57. Thomson AB. Small intestinal disorders in the elderly. Best Pract Res Clin Gastroenterol. 2009; 23(6):861–874.

58 58. Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009; 18(3):349–358.

59 59. Trahair LG, Horowitz M, Jones KL. Postprandial hypotension: a systematic review. J Am Med Dir Assoc. 2014; 15(6):394–409.

60 60. Jones KL, Rigda RS, Buttfield MDM, et al. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes. Diabetes Obes Metab. 2019; 21(5):1158–1167.

61 61. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2003;2( 2):107–116.

62 62. Natale G, Pasquali L, Ruggieri S, Paparelli A, Fornai F. Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol Motil. 2008; 20(7):741–749.

63 63. Leow LP, Huckabee ML, Anderson T, Beckert L. The impact of dysphagia on quality of life in ageing and Parkinson’s disease as measured by the swallowing quality of life (SWAL‐QOL) questionnaire. Dysphagia. 2010; 25(3):216–220.

64 64. Leow LP, Beckert L, Anderson T, Huckabee ML. Changes in chemosensitivity and mechanosensitivity in aging and Parkinson’s disease. Dysphagia. 2012; 27(1):106–114.

65 65. Heetun ZS, Quigley EM. Gastroparesis and Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2012; 18(5):433–440.

66 66. Du YT, Rayner CK, Jones KL, Talley NJ, Horowitz M. Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management. Diabetes Care. 2018; 41(3):627–637.

67 67. Kuo P, Rayner CK, Horowitz M. Gastric emptying, diabetes, and aging. Clin Geriatr Med. 2007; 23(4):785–808, vi.

68 68. Marathe CS, Rayner CK, Jones KL, Horowitz M. Relationships between gastric emptying, postprandial glycemia, and incretin hormones. Diabetes Care. 2013; 36(5):1396–1405.

69 69. Watson LE, Xie C, Wang X, et al. Gastric emptying in patients with well‐controlled type 2 diabetes compared with young and older control subjects without diabetes. J Clin Endocrinol Metab. 2019; 104(8):3311–3319.

70 70. Coleski R, Anderson MA, Hasler WL. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients. Dig Dis Sci. 2009.

71 71. Sallam H, McNearney TA, Chen JD. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther. 2006; 23(6):691–712.

72 72. Roberts CG, Hummers LK, Ravich WJ, Wigley FM, Hutchins GM. A case‐control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut. 2006; 55(12):1697–1703.

73 73. Watson DI, Jamieson GG, Bessell JR, Devitt PG. Laparoscopic fundoplication in patients with an aperistaltic esophagus and gastroesophageal reflux. Dis Esophagus. 2006; 19(2):94–98.

74 74. Agrawal A, Khan MH, Whorwell PJ. Irritable bowel syndrome in the elderly: An overlooked problem? Dig Liver Dis. 2009; 41(10):721–724.

75 75. Drossman DA, Hasler WL. Rome IV‐Functional GI disorders: disorders of gut‐brain interaction. Gastroenterology. 2016; 150(6):1257–1261.

76 76. Brummond NR, Locke GR, 3rd, Choung RS, et al. Effects of birth cohorts on the irritable bowel syndrome support early‐life risk factors. Dig Dis Sci. 2015; 60(7):2112–2118.

77 77. Locke GR,3rd, Yawn BP, Wollan PC, Melton LJ,3rd, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004; 19(9):1025–1031.

78 78. Halder SL, Locke GR,3rd, Schleck CD, Zinsmeister AR, Melton LJ, 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a12‐year longitudinal population‐based study. Gastroenterology. 2007; 133(3):799–807.

79 79. Bharucha AE, Camilleri M. Functional abdominal pain in the elderly. Gastroenterol Clin North Am. 2001; 30(2):517–529.

80 80. Herve S, Beaugerie L, Bouhnik Y, et al. Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case‐control study. Neurogastroenterol Motil. 2009; 21(11):1170–e1102.

81 81. Bennett G, Talley NJ. Irritable bowel syndrome in the elderly. Best Pract Res Clin Gastroenterol. 2002; 16(1):63–76.

82 82. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014; 146(1):67–75 e65.

83 83. Nanayakkara WS, Gearry RB, Muir JG, et al. Gastrointestinal symptoms and FODMAP intake of aged‐care residents from Christchurch, New Zealand. Nutrients. 2017; 9(10).

84 84. Linedale EC, Andrews JM. Diagnosis and management of irritable bowel syndrome: a guide for the generalist. Med J Aust. 2017; 207(7):309–315.

85 85. Van Oudenhove L, Tack J. Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia? Nat Clin Pract Gastroenterol Hepatol. 2009; 6(2):74–75.

86 86. Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non‐opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol. 2018; 15(3):168–180.